Our Vision

To be recognized as a global leader in the rapid delivery of innovative medical device solutions that improve patient outcomes, simplify physician adoption and reduce the cost of healthcare.

Our Mission

We improve the lives of women by delivering the most advanced minimally invasive medical devices in the world for treating common gynecological diseases.

Company Milestones

Founded in 2006
April 2007; closed Series A financing of $3.0M
April 2008; FDA 510(K) Clearance of first generation tissue removal system
July 2008; closed Series B financing of $4.0M
July 2008; FDA Clearance of diagnostic access sheath and flexible hysteroscope
June 2009; closed Series C financing of $20.5M
August 2009; FDA 510(K) Clearance of MyoSure™ Rod Len Hysteroscope
October 2009; FDA 510(K) Clearance of MyoSure™ Hysteroscopic Tissue Removal System